A startup developing 3D game-based medical devices to comprehensively assess and treat executive function in children with ADHD. By combining game design with neuroscience, it advances digital transformation in healthcare and expands possibilities for supporting diverse children.
We are a company dedicated to the social implementation of molecular simulation technologies developed in the Washizu Laboratory at the University of Hyogo. Our office is located on the University of Hyogo campus in Kobe’s Port Island, adjacent to the supercomputer Fugaku. We currently provide analysis and R&D support using large-scale molecular simulations, and we are also developing a molecular–fluid coupled simulator as well as mesoscale simulators for material surfaces based on particle methods.
A startup developing allogeneic T-cell therapies from pluripotent stem cells to provide novel treatments for advanced and recurrent cancers and immune-related diseases. Aiming to deliver the potential for a cure to diseases that were previously difficult to treat.
We offer three core services: “Actaba” for detecting abandoned farmland, “Detaba” for estimating crop classification, and “Ninataba” for connecting farmland with people. By leveraging satellite data and land parcel information, we visualize farmland to promote effective use and sustainability. We also support environmental conservation and regenerative agriculture through soil analysis, calculation of GHG emissions and carbon removal (aligned with SBTi-FLAG), carbon credit projects, and the promotion of decarbonized agricultural materials.
We develop “Reha3.0,” an AI application that analyzes sleep-time vital data to identify and visualize individuals at high risk of falls. By classifying fall risk into three levels and issuing alerts only for high-risk individuals, Reha3.0 reduces unnecessary alerts and enables up to an 80% reduction in monitoring workload.